Glucocorticoids suppress selected components of the senescence-associated secretory phenotype

Aging Cell

Volumn 11, Issue 4, 2012, Pages 569-578

  Laberge, Remi Martin ^a   Zhou, Lili ^a,b   Sarantos, Melissa R ^a   Rodier, Francis ^c   Freund, Adam ^a   de Keizer, Peter L J ^a   Liu, Su ^a   Demaria, Marco ^a   Cong, Yu Sheng ^b   Kapahi, Pankaj ^a   Desprez, Pierre Yves ^a,d   Hughes, Robert E ^a   Campisi, Judith ^a,e  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^b BEIJING NORMAL UNIVERSITY   (China)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Aging; Cancer; IL 6; IL 8; Inflammation; MMP 3

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; MIFEPRISTONE;

ARTICLE; CANCER INVASION; CELL AGING; FIBROBLAST; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE;

CELL AGING; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CORTICOSTERONE; FIBROBLASTS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; NEOPLASM INVASIVENESS; NF-KAPPA B; PHENOTYPE; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 84864010194     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/j.1474-9726.2012.00818.x     Document Type: Article

References (42)

1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Furnagalli M, DaCosta M, Brown C, Popov N, Takastu Y, Yabuta N, Melamed J, d'Adda di Fagagna F, Bernard D, Hernando E, Gil J (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018.
2. Adams PD (2009) Healing and hurting: molecular mechanisms, functions and pathologies of cellular senescence. Mol. Cell. 36, 2-14.
3. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232-236.
4. Bartholomew JN, Volonte D, Galbiati F (2009) Caveolin-1 regulates the antagonistic pleiotropic properties of cellular senescence through a novel Mdm2/p53-mediated pathway. Cancer Res. 69, 2878-2886.
5. Beausejour CM, Campisi J (2006) Ageing: balancing regeneration and cancer. Nature 443, 404-405.
6. Cadepond F, Ulmann A, Baulieu EE (1997) RU486 (mifepristone): mechanisms of action and clinical uses. Annu. Rev. Med. 48, 129-156.
7. Campisi J (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 11, 27-31.
8. Campisi J (2003) Cancer and ageing: rival demons? Nat. Rev. Cancer 3, 339-349.
9. Campisi J (2011) Cellular senescence: putting the paradoxes in perspective. Curr. Opin. Genet. Dev. 21, 107-112.
10. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, Carter C, Yu BP, Leeuwenburgh C (2009) Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res. Rev. 8, 18-30.
11. Collado M, Serrano M (2010) Senescence in tumours: evidence from mice and humans. Nat. Rev. Cancer 10, 51-57.
12. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz D, Goldstein J, Nelson PS, Desprez PY, Campisi J (2008) Senescence-associated secretory phenotypes reveal cell non-autonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
13. Coppe JP, Patil CK, Rodier F, Krtolica A, Beausejour C, Parrinello S, Hodgson G, Chin K, Desprez PY, Campisi J (2010) A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen. PLoS ONE 5, e9188.
14. Coppé JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118.
15. Davalos AR, Coppe JP, Campisi J, Desprez PY (2010) Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev. 29, 273-283.
16. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre M, Nuciforo PG, Bensimon A, Maestro R, Pelicci PG, d'Adda di Fagagna F (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638-642.
17. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith OM, Peacocke M, Campisi J (1995) A novel biomarker identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367.
18. Ferrucci L, Ble A, Bandinelli S, Lauretani F, Suthers K, Guralnik JM (2004) A flame burning within. Aging Clin. Exp. Res. 16, 240-243.
19. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S (2007) Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128, 92-105.
20. Freund A, Orjalo A, Desprez PY, Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 16, 238-248.
21. Freund A, Patil PK, Campisi J (2011) p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J. 30, 1536-1548.
22. Gottipati S, Rao NL, Fung-Leung WP (2008) IRAK1: a critical signaling mediator of innate immunity. Cell. Signal. 20, 269-276.
23. Gross KL, Cidlowski JA (2008) Tissue-specific glucocorticoid action: a family affair. Trends Endocrinol. Metab. 19, 331-339.
24. Jun JI, Lau LF (2010) The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat. Cell Biol. 12, 676-685.
25. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657-667.
26. Krtolica A, Parrinello S, Lockett S, Desprez P, Campisi J (2001) Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl Acad. Sci. USA 98, 12072-12077.
27. Kuilman T, Michaloglou C, Vredeveld LCW, Douma S, van DoornR, Desmet CJ, Aarden AL, Mooi WJ, Peeper DS (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031.
28. Laberge RM, Awad P, Campisi J, Desprez PY (in press) Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. doi: 10.1007/s12307-011-0069-4.
29. Liu D, Hornsby PJ (2007) Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67, 3117-3126.
30. Moghadam-Kia S, Werth VP (2010) Prevention and treatment of systemic glucocorticoid side effects. Int. J. Dermatol. 49, 239-248.
31. Oakley RH, Cidlowski JA (2011) Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. J. Biol. Chem. 286, 3177-3184.
32. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl Acad. Sci. USA 106, 17031-17036.
33. Parrinello S, Coppe JP, Krtolica A, Campisi J (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118, 485-496.
34. Perkins ND (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62.
35. Rodier F, Campisi J (2011) Four faces of cellular senescence. J. Cell Biol. 192, 547-556.
36. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat. Cell Biol. 11, 973-979.
37. Rodier F, Munoz DP, Teachenor R, Chu V, Le O, Bhaumik D, Coppe JP, Campeau E, Beausejour C, Kim SH, Davalos AR, Campisi J (2011) DNA-SCARS: distinct nuclear structures that sustain damage-induced senescence growth arrest and inflammatory cytokine secretion. J. Cell Sci. 124, 68-81.
38. Schlossmacher G, Stevens A, White A (2011) Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J. Endocrinol. 211, 17-25.
39. Tu Z, Aird KM, Bitler BG, Nicodemus JP, Beeharry N, Xia B, Yen TJ, Zhang R (2011) Oncogenic Ras regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence. Dev. Cell 21, 1077-1091.
40. Werman A, Werman-Venkert R, White R, Lee JK, Werman B, Krelin Y, Voronov E, Dinarello CA, Apte RN (2004) The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc. Natl Acad. Sci. USA 101, 2434-2439.
41. Williams GC (1957) Pleiotropy, natural selection, and the evolution of senescence. Evolution 11, 398-411.
42. Zanchi NE, Filho MA, Felitti V, Nicastro H, Lorenzeti FM, Lancha AH (2010) Glucocorticoids: extensive physiological actions modulated through multiple mechanisms of gene regulation. J. Cell. Physiol. 224, 311-315.